BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 21451111)

  • 21. NKT cells: T lymphocytes with innate effector functions.
    Van Kaer L
    Curr Opin Immunol; 2007 Jun; 19(3):354-64. PubMed ID: 17428648
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immediate antigen-specific effector functions by TCR-transgenic CD8+ NKT cells.
    Wingender G; Berg M; Jüngerkes F; Diehl L; Sullivan BA; Kronenberg M; Limmer A; Knolle PA
    Eur J Immunol; 2006 Mar; 36(3):570-82. PubMed ID: 16506291
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Circulating Valpha24+Vbeta11+ NKT cell numbers and dendritic cell CD1d expression in hepatitis C virus infected patients.
    van der Vliet HJ; Molling JW; von Blomberg BM; Kölgen W; Stam AG; de Gruijl TD; Mulder CJ; Janssen HL; Nishi N; van den Eertwegh AJ; Scheper RJ; van Nieuwkerk CJ
    Clin Immunol; 2005 Feb; 114(2):183-9. PubMed ID: 15639652
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role of marginal zone B lymphocytes in invariant NKT cell activation.
    Bialecki E; Paget C; Fontaine J; Capron M; Trottein F; Faveeuw C
    J Immunol; 2009 May; 182(10):6105-13. PubMed ID: 19414762
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Diverse antigen presentation by the Group 1 CD1 molecule, CD1c.
    Adams EJ
    Mol Immunol; 2013 Sep; 55(2):182-5. PubMed ID: 23127489
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Activation state and intracellular trafficking contribute to the repertoire of endogenous glycosphingolipids presented by CD1d [corrected].
    Muindi K; Cernadas M; Watts GF; Royle L; Neville DC; Dwek RA; Besra GS; Rudd PM; Butters TD; Brenner MB
    Proc Natl Acad Sci U S A; 2010 Feb; 107(7):3052-7. PubMed ID: 20133624
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antigen Presentation by CD1 Lipids, T Cells, and NKT Cells in Microbial Immunity.
    Cohen NR; Garg S; Brenner MB
    Adv Immunol; 2009; 102():1-94. PubMed ID: 19477319
    [TBL] [Abstract][Full Text] [Related]  

  • 28. BCR targeting of biotin-{alpha}-galactosylceramide leads to enhanced presentation on CD1d and requires transport of BCR to CD1d-containing endocytic compartments.
    Lang GA; Illarionov PA; Glatman-Freedman A; Besra GS; Lang ML
    Int Immunol; 2005 Jul; 17(7):899-908. PubMed ID: 15967785
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Presentation of alpha-galactosylceramide by murine CD1d to natural killer T cells is facilitated by plasma membrane glycolipid rafts.
    Lang GA; Maltsev SD; Besra GS; Lang ML
    Immunology; 2004 Jul; 112(3):386-96. PubMed ID: 15196206
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Molecular Analysis of Lipid-Reactive Vδ1 γδ T Cells Identified by CD1c Tetramers.
    Roy S; Ly D; Castro CD; Li NS; Hawk AJ; Altman JD; Meredith SC; Piccirilli JA; Moody DB; Adams EJ
    J Immunol; 2016 Feb; 196(4):1933-42. PubMed ID: 26755823
    [TBL] [Abstract][Full Text] [Related]  

  • 31. NKT and tolerance.
    Diana J; Beaudoin L; Gautron AS; Lehuen A
    Methods Mol Biol; 2011; 677():193-206. PubMed ID: 20941612
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CD1d-dependent activation of NKT cells aggravates atherosclerosis.
    Tupin E; Nicoletti A; Elhage R; Rudling M; Ljunggren HG; Hansson GK; Berne GP
    J Exp Med; 2004 Feb; 199(3):417-22. PubMed ID: 14744994
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differential contribution of dendritic cell CD1d to NKT cell-enhanced humoral immunity and CD8+ T cell activation.
    Joshi SK; Lang GA; Devera TS; Johnson AM; Kovats S; Lang ML
    J Leukoc Biol; 2012 May; 91(5):783-90. PubMed ID: 22331103
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Olea europaea pollen lipids activate invariant natural killer T cells by upregulating CD1d expression on dendritic cells.
    Abós-Gracia B; del Moral MG; López-Relaño J; Viana-Huete V; Castro L; Villalba M; Martínez-Naves E
    J Allergy Clin Immunol; 2013 May; 131(5):1393-9.e5. PubMed ID: 23265858
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Requirement for CD1d expression by B cells to stimulate NKT cell-enhanced antibody production.
    Lang GA; Devera TS; Lang ML
    Blood; 2008 Feb; 111(4):2158-62. PubMed ID: 18077787
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The tumor antigen N-glycolyl-GM3 is a human CD1d ligand capable of mediating B cell and natural killer T cell interaction.
    Gentilini MV; Pérez ME; Fernández PM; Fainboim L; Arana E
    Cancer Immunol Immunother; 2016 May; 65(5):551-62. PubMed ID: 26969612
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Alterations in cellular metabolism modulate CD1d-mediated NKT-cell responses.
    Webb TJ; Carey GB; East JE; Sun W; Bollino DR; Kimball AS; Brutkiewicz RR
    Pathog Dis; 2016 Aug; 74(6):. PubMed ID: 27297969
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tissue-specific segregation of CD1d-dependent and CD1d-independent NK T cells.
    Eberl G; Lees R; Smiley ST; Taniguchi M; Grusby MJ; MacDonald HR
    J Immunol; 1999 Jun; 162(11):6410-9. PubMed ID: 10352254
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Decreased CD1d level is associated with CD86 over-expression in B cells from systemic lupus erythematosus.
    Liu F; Ji J; Li X; Li X; Xu J; Yue H; Zhao S; Fan H; Hou Y
    Acta Biochim Biophys Sin (Shanghai); 2017 Apr; 49(4):328-337. PubMed ID: 28338767
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The bovine CD1 family contains group 1 CD1 proteins, but no functional CD1d.
    Van Rhijn I; Koets AP; Im JS; Piebes D; Reddington F; Besra GS; Porcelli SA; van Eden W; Rutten VP
    J Immunol; 2006 Apr; 176(8):4888-93. PubMed ID: 16585584
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.